|
Market Closed -
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.960 USD | -1.29% |
|
+1.43% | +27.69% |
| 25/08 | BioCryst Pharmaceuticals Announces Approval Of ORLADEYO For Pediatric HAE Patients In Japan | CI |
| 25/08 | BioCryst Pharmaceuticals Gets Japan Approval for Orladeyo in Young Children | MT |
Stock exchange
Nasdaq
BCRX 9.960 $
-1.29%
1.49Cr
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BCRX | 9.960USD | -1.29% | 1.49Cr $ | ||
CBOE
| BCRX | 9.955USD | -1.48% | 4L $ | |
|
Tradegate
| BO1 | 8.572EUR | -1.36% | 7.94T € | |
|
Mexican S.E.
| BCRX * | 182.00MXN | -6.67% | 18.2T $ | |
|
Boerse Muenchen
| BO1 | 8.570EUR | -0.90% | 591.33 € | |
|
Deutsche Boerse AG
| BO1 | 8.580EUR | -1.17% | 0 € | |
|
Börse Stuttgart
| BO1 | 8.560EUR | -1.20% | 0 € | |
|
Berne S.E.
| BO1 | 8.020CHF | -0.93% | 0 CHF |
Quotes 5-day view: BioCryst Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 31/08/2026 | 01/09/2026 | 02/09/2026 | 03/09/2026 | 04/09/2026 | |
|---|---|---|---|---|---|
| Last | $9.700 | $9.920 | $10.17 | $10.09 | $9.960 |
| Volume | 27,56,280 | 33,67,135 | 31,30,174 | 19,73,960 | 14,95,739 |
| Change | -1.22% | +2.27% | +2.52% | -0.79% | -1.29% |
| Opening | $9.720 | $9.720 | $10.00 | $10.15 | $10.00 |
| High | $9.720 | $9.955 | $10.23 | $10.22 | $10.10 |
| Low | $9.460 | $9.630 | $9.830 | $9.935 | $9.895 |
Performance
| 1 day | -1.29% | ||
| 1 week | +1.43% | ||
| Current month | +2.68% | ||
| 1 month | +10.42% | ||
| 3 months | +17.59% | ||
| 6 months | +16.22% | ||
| Current year | +27.69% | ||
| 1 year | +20.44% | ||
| 3 years | +36.81% | ||
| 5 years | -36.40% | ||
| 10 years | +137.14% |
Volumes
marketsDaily volume
14,95,739
Estimated daily volume
14,95,739
Avg. Volume 20 sessions
25,60,669
Daily volume ratio
0.58
Avg. Volume 20 sessions USD
2,55,04,263.24
Record volume 1
4,00,95,470
Record volume 2
3,75,50,050
Record volume 3
3,73,66,410
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
2,54,51,29,645
Net sales (USD)
87,48,37,000
Number of employees
435
Sales / Employee (USD)
20,11,120
Free-Float
94.77 %
Free-Float capitalization (USD)
2,41,19,87,532
Average Daily Capital Traded
1%
Indicators
Moving average 5 days
9.968
Moving average 20 days
9.876
Moving average 50 days
9.747
Moving average 100 days
9.328
Price spread / (MMA5)
+0.08%
Price spread / (MMA20)
-0.84%
Price spread / (MMA50)
-2.14%
Price spread / (MMA100)
-6.35%
RSI 9 days
58.82
RSI 14 days
56.27
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | +1.43% | +20.44% | +36.81% | 254.51Cr | |
| -1.79% | -2.27% | +50.90% | +89.03% | 6.8TCr | |
| -2.06% | -0.18% | +41.53% | +88.17% | 6.49TCr | |
| -0.31% | +6.54% | -11.39% | +457.82% | 2.76TCr | |
| -3.00% | -2.90% | +39.40% | +9.41% | 2.57TCr | |
| +0.86% | +1.65% | +0.25% | -14.78% | 2.61TCr | |
| -1.46% | +0.42% | +24.07% | -18.70% | 2.01TCr | |
| -2.96% | -15.21% | +210.71% | +370.84% | 1.72TCr | |
| -1.49% | -4.88% | -0.41% | +530.26% | 1.49TCr | |
| -0.20% | +8.37% | +57.87% | +159.50% | 1.46TCr | |
| Average | -1.37% | +0.37% | +43.34% | +170.84% | 2.82TCr | |
| Weighted average by Cap. | -1.52% | +0.19% | +42.09% | +144.10% |
Historical Quotes: BioCryst Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
307b2541719c1b6038a6d83.tgG3dxUCLeVG5n2u-WCBLe8zg1IpC7zXReHWoEPNBv0.9HjOQ0QvYJZxkDbHtyq2ZYh_9w1MW4qtfNC8xgKhSbvTUsIcR2NvyCnLMA
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 9.960 | 2,83,102 | 12,05,057 |
| 01:29:59 am | 9.960 | 200 | 9,21,955 |
| 01:29:59 am | 9.960 | 100 | 9,21,755 |
| 01:29:59 am | 9.950 | 100 | 9,21,655 |
| 01:29:59 am | 9.950 | 378 | 9,21,555 |
| 01:29:59 am | 9.950 | 100 | 9,21,177 |
| 01:29:59 am | 9.950 | 300 | 9,21,077 |
| 01:29:59 am | 9.950 | 600 | 9,20,777 |
| 01:29:56 am | 9.955 | 179 | 9,20,177 |
| 01:29:56 am | 9.955 | 200 | 9,19,998 |
Price Extremes
| 1 week | 9.46 |  | 10.23 |
| 1 month | 8.98 | | 10.68 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
Monthly variations
Annual variations
| 2026 | +27.69% | ||
| 2025 | +3.72% | ||
| 2024 | +25.54% | ||
| 2023 | -47.82% | ||
| 2022 | -17.11% | ||
| 2021 | +85.91% | ||
| 2020 | +115.94% | ||
| 2019 | -57.25% | ||
| 2018 | +64.36% | ||
| 2017 | -22.43% | ||
| 2016 | -38.66% | ||
| 2015 | -15.13% | ||
| 2014 | +60.00% | ||
| 2013 | +435.21% | ||
| 2012 | -42.51% | ||
| 2011 | -52.22% | ||
| 2010 | -19.97% | ||
| 2009 | +371.53% | ||
| 2008 | -77.83% | ||
| 2007 | -46.54% | ||
| 2006 | -30.99% | ||
| 2005 | +189.79% | ||
| 2004 | -15.62% | ||
| 2003 | +613.54% | ||
| 2002 | -75.76% | ||
| 2001 | -40.23% | ||
| 2000 | -77.54% | ||
| 1999 | +321.43% | ||
| 1998 | 0.00% | ||
| 1997 | -57.25% | ||
| 1996 | +77.03% | ||
| 1995 | +100.00% | ||
| 1994 | -28.85% |
- Stock Market
- Stocks
- BCRX Stock
- Quotes BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
